| Literature DB >> 28028481 |
Stephanie M Rosales1, Rebecca L Vega Thurber1.
Abstract
Diseases of marine mammals can be difficult to diagnose because of their life history and protected status. Stranded marine mammals have been a particularly useful resource to discover and comprehend the diseases that plague these top predators. Additionally, advancements in high-throughput sequencing (HTS) has contributed to the discovery of novel pathogens in marine mammals. In this study, we use a combination of HTS and stranded harbor seals (Phoca vitulina) to better understand a known and unknown brain disease. To do this, we used transcriptomics to evaluate brain tissues from seven neonatal harbor seals that expired from an unknown cause of death (UCD) and compared them to four neonatal harbor seals that had confirmed phocine herpesvirus (PhV-1) infections in the brain. Comparing the two disease states we found that UCD animals showed a significant abundance of fatty acid metabolic transcripts in their brain tissue, thus we speculate that a fatty acid metabolic dysregulation contributed to the death of these animals. Furthermore, we were able to describe the response of four young harbor seals with PhV-1 infections in the brain. PhV-1 infected animals showed a significant ability to mount an innate and adaptive immune response, especially to combat viral infections. Our data also suggests that PhV-1 can hijack host pathways for DNA packaging and exocytosis. This is the first study to use transcriptomics in marine mammals to understand host and viral interactions and assess the death of stranded marine mammals with an unknown disease. Furthermore, we show the value of applying transcriptomics on stranded marine mammals for disease characterization.Entities:
Keywords: Burkholderia; Fatty acid metabolism; High-throughput sequencing; Marine mammal; Phocine herpesvirus
Year: 2016 PMID: 28028481 PMCID: PMC5182994 DOI: 10.7717/peerj.2819
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Stranding information for harbor seal samples used in this study.
| Sample ID | Date of stranding | Date of death | Date of necropsy | Common lesions | Age | Sex | Tissue | Weight in kilo- grams at necropsy |
|---|---|---|---|---|---|---|---|---|
| UCD1 | 4/8/09 | 7/1/09 | 7/2/09 | Neuronal necrosis in the cortex and cerebellum, and hepatic lipidosis | Weaner | M | Cerebrum back | 9.6 |
| UCD2 | 4/9/09 | 7/26/09 | 7/29/09 | Neuronal necrosis in the cortex and cerebellum, splenic hemosiderosis, spleen extramedullary hematopoiesis, and hepatic lipidosis | Weaner | F | Cerebellum front | 11.0 |
| UCD3 | 4/11/09 | 4/21/09 | 4/22/09 | Neuronal necrosis in the cortex and cerebellum, splenic hemosiderosis, and spleen extramedullary hematopoiesis | Weaner | M | Cerebrum front | 11.9 |
| UCD4 | 4/17/09 | 7/6/09 | 7/6/09 | Neuronal necrosis in the cortex and cerebellum, splenic hemosiderosis, spleen extramedullary hematopoiesis, and hepatic lipidosis | Weaner | F | Cerebrum front | 13.0 |
| UCD5 | 4/20/09 | 7/12/09 | 7/13/09 | Neuronal necrosis in the cortex and cerebellum, and spleen extramedullary hematopoiesis | Weaner | F | Cerebrum front | 10.8 |
| UCD6 | 5/2/09 | 6/26/09 | 6/27/09 | Neuronal necrosis in the cortex and cerebellum, splenic hemosiderosis, spleen extramedullary hematopoiesis, and hepatic lipidosis | Weaner | M | Cerebrum front | 10.0 |
| UCD7 | 6/1/09 | 7/16/09 | 7/16/09 | Neuronal necrosis in the cortex and cerebellum, splenic hemosiderosis, and spleen extramedullary hematopoiesis | Weaner | F | Cerebrum front | 8.7 |
| PhV-1com3 | 3/14/10 | 5/2/10 | 5/3/10 | Necrosis in the liver, adrenal gland, and lymph tissue | Weaner | M | Cerebrum front | 7.5 |
| PhV-1com5 | 3/29/11 | 4/7/11 | 4/8/11 | Hemorrhagic and congested lungs, mottled liver, congested meninges, intestinal necrosis, necrosis in the liver, and adrenal gland | Pup | M | Cerebrum front | 7.5 |
| PhV-1com6 | 4/16/11 | 4/24/11 | 4/25/11 | Fat atrophy, omphalophebitis, enlarged mesenteric lymph nodes, thickeded umbilicus, and necrosis in the liver and lung | Pup | M | Cerebrum front | 11.0 |
| PhV-1com7 | 5/25/12 | 5/25/12 | 5/26/12 | Omphalophebitis, necrotizing splentitis, hepatitis, and adrenalitis | Pup | F | Cerebrum front/back | 8.3 |
Figure 1Batch effects on transcripts from the brain tissue of harbor seal samples.
Principal Coordinate Analysis (PCA) of all annotated transcripts in both PhV-1com and UCD harbor seals.
Figure 2Semantically summarized GO terms.
Tree map summary of 32 significantly enriched GO terms (p-value ≤ 0.05, and multifunctionality ≤ 0.85) of both UCD and PhV-1 samples. The blocks are clustered by related terms and the size of the boxes are based on log10 transformed p-values from GO enrichment analysis. Larger boxes represent more significant p-values.
Figure 3Significant differentially expressed genes (padj ≤ 0.05) within GO categories that were significantly enriched in the harbor seal transcriptome (GO p-value ≤ 0.05 and multifunctionality of ≤0.85).
Heatmap of normalized gene counts expressed in rlog transformation (row z-score) from PhV1com and UCD harbor seals. Scatter plot of log2 fold change between PhV1 and UCD. The respective DEG padj values for each gene are represented by circles, with smaller circles denoting smaller padj values. Category: purple = GO term: fatty acid metabolic process, orange = GO terms: defense response to virus, and response to virus, grey = the other 29 GO terms that were significantly enriched in the harbor seal transcriptome.
Figure 4KEGG pathway involved in human herpes-simplex-1 (HSV-1) showing similarities in host gene responses upon a PhV-1 infection.
Highlighted gray boxes represent terms that were significantly enriched DEGs in PhV-1 infected seals (DESeq2 padj ≤ 0.05).
Transcripts in UCD samples involved in fatty acid metabolism.
Fatty acid metabolism transcripts that were significantly up-regulated (DEGs padj ≤ 0.05) in UCD harbor seals and annotated using UniProt, GO terms, KEGG GENES and KO pathways.
| Gene ID | UniProt annotation | GO category | KEGG annotation | KO pathway | Fold change | Padj |
|---|---|---|---|---|---|---|
| TR11985_c0 | Elongation of very long chain fatty acids protein | Fatty acid metabolic process | Elongation of very long chain fatty acids protein 5 | Fatty acid metabolism, biosynthesis of unsaturated fatty acids, and fatty acid elongation | 0.697 | 0.001 |
| TR13138_c0 | Fatty acid 2-hydroxylase | Fatty acid metabolic process and fatty acid biosynthesis | 4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase | NA | 0.99 | 0.003 |
| TR5359_c0 | Fatty acid desaturase 2 | Fatty acid metabolic process and fatty acid biosynthesis | Fatty acid desaturase 2 | PPAR signaling pathway, fatty acid metabolism, biosynthesis of unsaturated fatty acid, and alpha-Linolenic acid metabolism | 0.49 | 0.011 |
| TR15982_c0 | Long-chain specific acyl-CoA dehydrogenasemitochondrial | Fatty acid metabolic process | Long-chain-acyl-CoA dehydrogenase | NA | 0.469 | 0.007 |
| TR7794_c0 | Long-chain-fatty-acid–CoA ligase 1 | Fatty acid metabolic process | Long-chain acyl-CoA synthetase | Fatty acid biosynthesis, fatty acid degradation, fatty acid metabolism, PPAR signaling pathway, Peroxisome, and adipocytokine signaling pathway | 0.424 | 0.036 |
| TR9787_c0 | Medium-chain specific acyl-CoA dehydrogenasemitochondrial | Fatty acid metabolic process | Acyl-CoA dehydrogenase | Fatty acid metabolism, PPAR signaling pathway, Carbon metabolism, beta-Alanine metabolism , valine, leucine isoleucine degradation, Fatty acid degradation, and propanoate metabolism | 0.831 | 2.37E–06 |
| TR283_c0 | Stearoyl-CoA desaturase variant (Fragment) | Fatty acid metabolic process and fatty acid biosynthesis | Stearoyl-CoA desaturase | AMPK signaling pathway, fatty acid metabolism, PPAR signaling pathway, biosynthesis of unsaturated fatty acids, and longevity regulating pathway—worm | 1.354 | 1.28E–13 |
| TR1355_c0 | Sterol-C4-methyl oxidase-like protein (Fragment) | Fatty acid metabolic process | Methylsterol monooxygenase | Steroid biosynthesis | 0.856 | 0.003 |
| TR10658_c1 | Sterol-C5-desaturase-like protein (Fragment) | Fatty acid metabolic process and fatty acid biosynthesis | Delta7-sterol 5-desaturase | Steroid biosynthesis | 0.957 | 9.69E–05 |
Notes.
peroxisome proliferator-activated receptors.
adenosine monophosphateactivated protein kinase